AbCellera Biologics Inc.ABCLNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank86
3Y CAGR+7.6%
5Y CAGR+39.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+7.6%/yr
vs +119.7%/yr prior
5Y CAGR
+39.5%/yr
Recent deceleration
Acceleration
-112.1pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
5.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$83.23M-2.6%
2024$85.49M+13.7%
2023$75.18M+12.6%
2022$66.75M+36.9%
2021$48.76M+209.6%
2020$15.75M+292.6%
2019$4.01M+40.1%
2018$2.86M-